These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6724593)

  • 1. Monitoring of adverse drug reactions by means of autopsy tissue examination.
    Mikhael NZ; Kacew S
    Hum Toxicol; 1984 Apr; 3(2):133-40. PubMed ID: 6724593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autopsy tissue examination: a novel method to estimate adverse reactions to pharmacological agents.
    Mikhael NZ; Boggs M; Kacew S; Potvin DL
    J Environ Pathol Toxicol Oncol; 1986; 6(3-4):345-50. PubMed ID: 3712249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of morphologic tissue examinations as novel technique for estimation of drug adverse reactions in hospitalized patients.
    Mikhael NZ; Boggs M; Kacew S; Potvin DL
    J Environ Pathol Toxicol Oncol; 1986; 6(3-4):315-21. PubMed ID: 3712246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse tissue reactions to drugs: a five-year surveillance study.
    Mikhael NZ; Kacew S
    Hum Toxicol; 1985 Nov; 4(6):583-90. PubMed ID: 4077070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the Adverse Reactions Register to study the effects of age and sex on adverse drug reactions.
    Simpson JM; Bateman DN; Rawlins MD
    Stat Med; 1987; 6(7):863-7. PubMed ID: 3423506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.
    Tegeder I; Levy M; Muth-Selbach U; Oelkers R; Neumann F; Dormann H; Azaz-Livshits T; Criegee-Rieck M; Schneider HT; Hahn E; Brune K; Geisslinger G
    Br J Clin Pharmacol; 1999 May; 47(5):557-64. PubMed ID: 10336581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic changes in adverse drug reactions in infants and children.
    Mullick FG; Drake RM; Irey NS
    Hum Pathol; 1977 Jul; 8(4):361-78. PubMed ID: 302237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency Department Visits for Adverse Drug Reactions Involving Alcohol: United States, 2005 to 2011.
    Castle IJ; Dong C; Haughwout SP; White AM
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1913-25. PubMed ID: 27488763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).
    Iasella CJ; Johnson HJ; Dunn MA
    Clin Liver Dis; 2017 Feb; 21(1):73-87. PubMed ID: 27842776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?
    Lau PM; Stewart K; Dooley M
    Support Care Cancer; 2004 Sep; 12(9):626-33. PubMed ID: 15064936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characterization of adverse drug reactions in adults over 44 years of age in Bogota, January-December, 2012].
    Chaves M
    Biomedica; 2015; 35(1):34-42. PubMed ID: 26148032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.
    Greil W; Häberle A; Schuhmann T; Grohmann R; Baumann P
    Swiss Med Wkly; 2013; 143():w13772. PubMed ID: 23821346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
    Mittal N; Gupta M; Singla M
    Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?
    Carbonin P; Pahor M; Bernabei R; Sgadari A
    J Am Geriatr Soc; 1991 Nov; 39(11):1093-9. PubMed ID: 1753048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive drug surveillance--a pilot study.
    Gerke DC; Easterbrook EG; Frewin DB; Lee TI
    Aust N Z J Med; 1975 Aug; 5(4):336-40. PubMed ID: 1058672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden.
    Holm L; Ekman E; Jorsäter Blomgren K
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):335-343. PubMed ID: 28071845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspected drug-induced hepatic reactions reported to the FDA's adverse reaction system: an overview.
    Jones JK
    Semin Liver Dis; 1981 May; 1(2):157-67. PubMed ID: 7051297
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive monitoring of adverse drug reactions in infants and preschool children.
    Cirko-Begović A; Vrhovac B; Bakran I
    Eur J Clin Pharmacol; 1989; 36(1):63-5. PubMed ID: 2917590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.